PROM1 and cervical cancer: Surgery did not significantly alter percentages of CD133+ CTCs in the surgery only (grey dots), aRT (middle orange dots) or aCRT (middle blue dots) cohorts in patients with vulvar or cervical cancer (Fig. 3A, B).